LogicBio Therapeutics' Series A Round

LogicBio Therapeutics raised a round of funding on January 21, 2016. Investors include OrbiMed Advisors.

LogicBio Therapeutics is focused on gene therapy, targeting "lifelong cures" for serious, early-onset rare diseases by combining the best of gene therapy and gene editing in a one-time treatment.…

Articles about LogicBio Therapeutics' Series A Round: